MARKET

ROIV

ROIV

Roivant Sciences
NASDAQ
7.69
-0.10
-1.28%
Closed 18:30 02/08 EST
OPEN
7.80
PREV CLOSE
7.79
HIGH
7.95
LOW
7.69
VOLUME
2.16M
TURNOVER
--
52 WEEK HIGH
10.00
52 WEEK LOW
2.520
MARKET CAP
5.58B
P/E (TTM)
-4.5289
1D
5D
1M
3M
1Y
5Y
Roivant Sciences prices upsized public offering of $200M
Seeking Alpha · 6d ago
Roivant Sciences Announces Pricing Of $200M Upsized Public Offering Of 26,666,666 Shares Of Common Stock At A Price Of $7.50/Share
Benzinga · 6d ago
Roivant Sciences Prices $200 Million Upsized Common Stock Offering
Roivant Sciences Prices $200 Million Upsized Common Stock Offering
MT Newswires · 6d ago
BRIEF-Roivant Sciences Prices Upsized Underwritten Public Offering Of 26.7 Million Of Common Shares At $7.50/Share
Reuters · 6d ago
Roivant Sciences Launches $150 Million Common Stock Offering
Roivant Sciences Launches $150 Million Common Stock Offering
MT Newswires · 02/02 03:47
BRIEF-Roivant Sciences Provides An Update On Its Financial Results For The Third Quarter
Reuters · 02/01 23:54
BRIEF-Roivant Sciences Announces Proposed Public Offering Of Common Shares
Reuters · 02/01 22:56
Roivant launches $150M stock offering, shares fall
Seeking Alpha · 02/01 21:38
More
About ROIV
Roivant Sciences Ltd. is a pharma company. The Company is focused on developing transformative medicines that address areas of unmet medical need. The Company, through its subsidiaries, is focused on delivering medicines and technologies to patients. The Company builds biotech and healthcare technology companies (Vants) and deploys technology to drive research and development and commercialization. The Company’s product candidate includes VTAMA (tapinarof), IMVT-1401, Brepocitinib, Namilumab and RVT-2001. Its Vant family includes Dermavant, Immunovant, Priovant, Kinevant and Hemavant. Its small molecule discovery engine is powered by computational physics and machine learning (ML) capabilities for in silico drug design. The Company’s capabilities in diverse therapeutic areas, including immunology, dermatology and oncology, and modalities, including biologics, topicals and bifunctional small molecules.

Webull offers kinds of Roivant Sciences Ltd stock information, including NASDAQ:ROIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ROIV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ROIV stock methods without spending real money on the virtual paper trading platform.